Digital health technologies can reduce visit burden and collect remote data, but weak participant onboarding can turn device setup, connectivity, and missing data into recruitment and retention problems.
How this resource is reviewed
Reviewed by TrialsNest editorial review on . These guides are written for operational education and updated when workflow, buyer, or trust boundaries change.
How to use the tool without making it busywork
A useful digital health technology clinical trials should produce an owner, blocker, date, decision, or next action. If it only creates another document, the workflow still needs a sharper operating habit.
Completing the checklist away from the queue
The best review happens beside real work, where missing records, stale leads, and owner gaps are visible.
Leaving the result out of the next meeting
A checklist should feed the next coordinator, site, sponsor, or operations conversation.
Decision checklist
Gather the current owner, status, blocker, source, and last meaningful movement.
Mark which answers need action instead of treating every item as equal.
Put the owner, due date, or reporting note back into the workflow.
What to keep in view
Operator questions
How teams usually use it
Compare it with the real queue
Read it next to the way your team already works. The gaps usually show up around ownership, missing records, follow-up timing, or sponsor-update prep.
Mark the handoffs
For each section, ask where the work changes hands. If the handoff depends on memory, a spreadsheet tab, or a buried message, that is probably worth fixing.
Keep the boundary clear
When the topic touches matching or prescreening, keep the language careful. Early fit is not enrollment, and final study decisions stay with authorized study teams.
A practical use case
Use the checklist during a live recruitment review, then convert the answer into a queue update, sponsor note, source-quality decision, or follow-up task.
Focused next reads for this topic
These links keep the page inside the same practical topic path instead of sending readers through broad navigation.
Practical resources for sponsor and CRO teams comparing recruitment reporting software, enrollment updates, source quality, site blockers, dashboards, and next-action visibility.
Patient-reported outcomes can capture how participants feel or function directly from the patient, but collection needs to be understandable, accessible, and burden-aware.
Results reporting may be owned by sponsors or responsible parties, but clean site-level documentation makes late-stage reconciliation, recruitment status review, and handoffs easier.
Source quality is the difference between lead volume that looks good and patient interest a site can actually work.
Turn this guide into a working recruitment workflow.
Walk through how patient intake, prescreening, records readiness, scheduling, and reporting connect in the product.
Remote data still needs an operating model
Digital health technologies can reduce visit burden and capture data remotely, but only if participants can use them consistently. A device or app that looks simple in a vendor demo can become a recruitment and retention problem if onboarding is weak.
FDA's final guidance on Digital Health Technologies for Remote Data Acquisition in Clinical Investigations provides recommendations for using DHTs to collect remote data from participants in medical product clinical investigations.
Build onboarding around the participant
Participant onboarding should explain what the device or app collects, when and how often it should be used, whether charging or connectivity is required, and who handles technical questions.
The team should also define what happens if data is missing, whether setup should be tested before relying on remote data, and how privacy and data-use language will be explained in patient-facing terms.
Case-study example
A study uses a wearable to collect activity data but does not confirm whether participants can charge it, sync it, or wear it during normal routines. Missing data later appears as noncompliance, but the root cause may be onboarding and support.
A stronger workflow would verify setup, document readiness, name the technical support path, and give coordinators a clear status for device not received, setup incomplete, syncing issue, participant question, or data missing.
Where TrialsNest fits
TrialsNest can support the operational layer by keeping device readiness, coordinator outreach, missed setup steps, and follow-up tasks visible. That helps sites separate patient burden from technical friction.
The platform should not imply that remote monitoring replaces medical care. Patient-facing language should keep remote data collection, study-team review, and regular medical care clearly separated.
Sources used for this checklist
FDA Digital Health Technologies for Remote Data Acquisition guidance: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/digital-health-technologies-remote-data-acquisition-clinical-investigations
FDA Digital Health Technologies for drug development: https://www.fda.gov/science-research/science-and-research-special-topics/digital-health-technologies-dhts-drug-development
Turn this guidance into a repeatable workflow.
Walk through how sites can reduce stale leads, preserve coordinator context, and move qualified patients toward scheduled next steps.
Related TrialsNest workflows
These resource pages connect back to the product areas buyers usually ask about: public study search, site recruitment workflow, sponsor visibility, and the privacy-aware operating model.
Use the operational steps to tighten ownership, stale-lead review, records readiness, reminders, and visit preparation.
Walk through how TrialsNest can organize the daily recruiting queue without adding PHI-processing routes to the public frontend.
Topics covered
Common questions
What should teams know about digital health technology clinical trials?
Digital health technologies can reduce visit burden and collect remote data, but weak participant onboarding can turn device setup, connectivity, and missing data into recruitment and retention problems. The practical value is in connecting the concept to ownership, follow-up, records readiness, scheduling, reporting, and clear next actions.
Who is this resource written for?
This resource is written for clinical operations sorting through practical questions around digital health technology clinical trials and the workflow decisions that usually come with it.
Does this guide replace study-team review or medical advice?
No. TrialsNest resources are educational and operational. They do not provide medical advice, diagnosis, treatment, emergency care, or final clinical trial eligibility decisions.
How would a team use this workflow guidance in practice?
Use it to compare the current workflow with what actually happens day to day: where leads wait, where records get lost, where follow-up slows down, and what needs a clearer owner. The best next step is to turn the article takeaways into a short review checklist for digital health technology clinical trials.
Trust and proof points
Study-team decisions stay with authorized teams
TrialsNest can organize intake, prescreening, and workflow context, but it does not make final eligibility, enrollment, treatment, or medical decisions.
Reporting focuses on operational movement
Sponsor-ready updates should show source quality, movement, blockers, and next actions without becoming a broad patient-detail workspace.
Public pages stay educational
These resources explain clinical recruiting workflows and buying decisions. Sensitive study details belong in the appropriate secure workflow.
Continue exploring
Helpful next reads
Follow-up reading chosen from the same topic cluster and audience context as this guide.